Effect of beta-blocker therapy in patients with coronary artery disease in New York Heart Association classes II and III. The Bezafibrate Infarction Prevention (BIP) Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples